Lenvatinib/Pembro Combo for Advanced Anaplastic Thyroid Cancer Lenvatinib/Pembro Combo for Advanced Anaplastic Thyroid Cancer

The nonchemotherapy combination has shown durable responses in patients with metastatic anaplastic thyroid cancer that has progressed on chemotherapy.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news